| Literature DB >> 27402444 |
Konstantinos Marmagkiolis1, Mehmet Cilingiroglu2.
Abstract
Thrombus formafigtion plays a significant role in disease of saphenous vein bypass grafts. Use of oral anticoagulants has not been tested in treatment of thrombotic occlusion of saphenous vein graft (SVG) disease. Here we describe the use of the novel oral anticoagulant rivaroxaban in the treatment of occlusive SVG disease with intraluminal thrombus, leading to successful recanalization.Entities:
Keywords: Anticoagulant; Anticoagulantes; Doença do enxerto da veia safena; Saphenous vein graft disease; Thrombus; Trombose
Mesh：
Substances：
Year: 2016 PMID： 27402444 DOI： 10.1016/j.repc.2015.11.024
Source DB: PubMed Journal: Rev Port Cardiol ISSN： 0870-2551 Impact factor: 1.374